190 related articles for article (PubMed ID: 16311091)
1. Effects of thorough mastication on postprandial plasma glucose concentrations in nonobese Japanese subjects.
Suzuki H; Fukushima M; Okamoto S; Takahashi O; Shimbo T; Kurose T; Yamada Y; Inagaki N; Seino Y; Fukui T
Metabolism; 2005 Dec; 54(12):1593-9. PubMed ID: 16311091
[TBL] [Abstract][Full Text] [Related]
2. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
[TBL] [Abstract][Full Text] [Related]
3. Effects of the dipeptidyl peptidase-IV inhibitor vildagliptin on incretin hormones, islet function, and postprandial glycemia in subjects with impaired glucose tolerance.
Rosenstock J; Foley JE; Rendell M; Landin-Olsson M; Holst JJ; Deacon CF; Rochotte E; Baron MA
Diabetes Care; 2008 Jan; 31(1):30-5. PubMed ID: 17947341
[TBL] [Abstract][Full Text] [Related]
4. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
5. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose.
Abdul-Ghani MA; Williams K; DeFronzo R; Stern M
Diabetes Care; 2006 Jul; 29(7):1613-8. PubMed ID: 16801587
[TBL] [Abstract][Full Text] [Related]
6. [Characteristics of dysfunction of islet beta-cell in newly diagnosed type 2 diabetic patients].
Li YB; Zhu DL; Tian HM; Shi LX; Luo ZJ; Yan L; Zeng LY; Zhou ZG; Yang LY; Liu J; Li M; Weng JP
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2537-41. PubMed ID: 17198561
[TBL] [Abstract][Full Text] [Related]
7. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA
Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675
[TBL] [Abstract][Full Text] [Related]
8. Effects of exogenous glucagon-like peptide-1 on gastric emptying and glucose absorption in the critically ill: relationship to glycemia.
Deane AM; Chapman MJ; Fraser RJ; Summers MJ; Zaknic AV; Storey JP; Jones KL; Rayner CK; Horowitz M
Crit Care Med; 2010 May; 38(5):1261-9. PubMed ID: 20228679
[TBL] [Abstract][Full Text] [Related]
9. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
[TBL] [Abstract][Full Text] [Related]
10. Short-term and long-term effects of guar on postprandial plasma glucose, insulin and glucagon-like peptide 1 concentration in healthy rats.
Prieto PG; Cancelas J; Villanueva-Peñacarrillo ML; Malaisse WJ; Valverde I
Horm Metab Res; 2006 Jun; 38(6):397-404. PubMed ID: 16823722
[TBL] [Abstract][Full Text] [Related]
11. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
[TBL] [Abstract][Full Text] [Related]
12. Effects of breakfast meal composition on second meal metabolic responses in adults with Type 2 diabetes mellitus.
Clark CA; Gardiner J; McBurney MI; Anderson S; Weatherspoon LJ; Henry DN; Hord NG
Eur J Clin Nutr; 2006 Sep; 60(9):1122-9. PubMed ID: 16670695
[TBL] [Abstract][Full Text] [Related]
13. Arabinoxylan consumption decreases postprandial serum glucose, serum insulin and plasma total ghrelin response in subjects with impaired glucose tolerance.
Garcia AL; Otto B; Reich SC; Weickert MO; Steiniger J; Machowetz A; Rudovich NN; Möhlig M; Katz N; Speth M; Meuser F; Doerfer J; Zunft HJ; Pfeiffer AH; Koebnick C
Eur J Clin Nutr; 2007 Mar; 61(3):334-41. PubMed ID: 16988651
[TBL] [Abstract][Full Text] [Related]
14. No acute effect of nateglinide on postprandial lipid and lipoprotein responses in subjects at risk for type 2 diabetes.
Johanson EH; Jansson PA; Gustafson B; Sandqvist M; Taskinen MR; Smith U; Axelsen M
Diabetes Metab Res Rev; 2005; 21(4):376-81. PubMed ID: 15724236
[TBL] [Abstract][Full Text] [Related]
15. Direct assessment of muscle glycogen storage after mixed meals in normal and type 2 diabetic subjects.
Carey PE; Halliday J; Snaar JE; Morris PG; Taylor R
Am J Physiol Endocrinol Metab; 2003 Apr; 284(4):E688-94. PubMed ID: 12453829
[TBL] [Abstract][Full Text] [Related]
16. Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance.
Muscelli E; Mari A; Natali A; Astiarraga BD; Camastra S; Frascerra S; Holst JJ; Ferrannini E
Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1144-50. PubMed ID: 16478775
[TBL] [Abstract][Full Text] [Related]
17. The acute impact of ingestion of breads of varying composition on blood glucose, insulin and incretins following first and second meals.
Najjar AM; Parsons PM; Duncan AM; Robinson LE; Yada RY; Graham TE
Br J Nutr; 2009 Feb; 101(3):391-8. PubMed ID: 18570696
[TBL] [Abstract][Full Text] [Related]
18. Miglitol suppresses the postprandial increase in interleukin 6 and enhances active glucagon-like peptide 1 secretion in viscerally obese subjects.
Arakawa M; Ebato C; Mita T; Fujitani Y; Shimizu T; Watada H; Kawamori R; Hirose T
Metabolism; 2008 Sep; 57(9):1299-306. PubMed ID: 18702958
[TBL] [Abstract][Full Text] [Related]
19. [The relationship between insulin resistance and postprandial abnormal serum triglyceride metabolism in essential hypertension].
Lin J; Peng F; Zeng K; Wu K; Kang Q
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1521-4. PubMed ID: 12609058
[TBL] [Abstract][Full Text] [Related]
20. Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes.
Linnebjerg H; Kothare PA; Skrivanek Z; de la Peña A; Atkins M; Ernest CS; Trautmann ME
Diabet Med; 2006 Mar; 23(3):240-5. PubMed ID: 16492205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
